Abstract
Key Points Covered balloon expandable stents have 2 year primary patency rates of approximately 85% compared to 75% for uncovered stents in complex aortoiliac disease. A reduction in the area and thickness of neointimal hyperplasia may explain the superior maintenance of post‐procedural ankle‐brachial index improvements and patency of covered stents for complex aortoiliac disease. Improved outcomes prediction based on anatomic disease (Trans‐Atlantic Inter‐Society Consensus disease classification) and clinical characteristics may inform patient‐specific device selection to improve long‐term outcomes and cost‐effectiveness in the endovascular treatment of aortoiliac disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
